Drug intelligence / Profile preview

Bionanomatrix DPC

Development stage
Preclinical
Lead developer
Endomimetics
Modality
Nanoparticles → Drug Delivery Systems, Peptides
Administration
Topical
01

Overview

Bionanomatrix DPC is a preclinical-stage dental medical device coating developed by Endomimetics in collaboration with BISCO, Inc. It utilizes a proprietary peptide-based nanomatrix technology consisting of self-assembling peptide amphiphiles designed for direct pulp capping procedures. The nanomatrix features dual functionality: one component is engineered to bind endothelial cells to facilitate tissue healing and regeneration, while the other provides the controlled, sustained release of nitric oxide (NO). This localized delivery of nitric oxide aims to provide antimicrobial and anti-inflammatory benefits and induce the formation of a mineralized dentin barrier. The technology is intended to maintain dental pulp vitality and improve clinical outcomes in the treatment of dental caries and pulp exposure, potentially replacing traditional pulp capping materials.

Other names
Bionanomatrix (NO-releasing dental coating)peptide-based nanomatrix coatingBionanomatrix-DPC-Endomimetics
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on Bionanomatrix DPC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionanomatrix DPC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call